Back to "There was no significant difference betw..."
Claim
Strong Support
descriptive
Analysis v3

Giving premature infants vitamin D by mouth or injection does not change their blood levels of calcium, phosphorus, or alkaline phosphatase within 15 days.

54
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Giving vitamin D to premature babies raises their vitamin D levels, but their kidneys and bones are too young to use it to pull calcium and phosphorus into the blood or release them from bone. So those mineral levels stay the same, even though vitamin D goes up.

Most probable mechanism

In Simple Terms

When vitamin D is given to premature babies, their bodies convert it into the active form, but their kidneys and bones are not yet mature enough to respond quickly by pulling calcium and phosphorus from the blood or releasing them from bone. As a result, blood levels of calcium, phosphorus, and the bone enzyme alkaline phosphatase stay the same even though vitamin D levels rise.

Causal chain
1

Vitamin D3 is absorbed from the gut or muscle tissue and transported to the liver, where it is converted to 25-hydroxyvitamin D3, increasing its concentration in the bloodstream.

Verified by multiple studies
which leads to
2

Elevated 25-hydroxyvitamin D3 reaches the kidneys, where it would normally stimulate 1α-hydroxylase to produce active 1,25-dihydroxyvitamin D3, but renal enzyme activity remains low due to developmental immaturity.

Supported by evidence
which leads to
3

Low levels of active 1,25-dihydroxyvitamin D3 fail to stimulate intestinal calcium and phosphorus absorption, despite sufficient precursor levels.

Supported by evidence
which leads to
4

Active vitamin D does not trigger increased osteoclast activity or bone mineral resorption because skeletal remodeling pathways are underdeveloped and unresponsive.

Supported by evidence
which leads to
5

Renal tubular reabsorption of calcium and phosphorus remains unchanged due to lack of parathyroid hormone sensitization and immature vitamin D receptor signaling in nephrons.

Supported by evidence
which leads to
6

Alkaline phosphatase levels remain stable because osteoblast activity and bone turnover are not accelerated in the absence of coordinated mineral mobilization signals.

Supported by evidence

Evidence from Studies

Supporting (1)

54

Community contributions welcome

54

Comparison of the Effect of Oral Versus Parenteral Vitamin D on Serum Levels of Vitamin D in Premature Infants with Vitamin D Deficiency

Randomized Controlled Trial
Human

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict

Source Study

Comparison of the Effect of Oral Versus Parenteral Vitamin D on Serum Levels of Vitamin D in Premature Infants with Vitamin D Deficiency

Score: 54
DOI: 10.5812/compreped-134297

Similar Assertions

In premature infants with low vitamin D levels, both a daily oral dose of 1,000 IU and a single injection of 15,000 IU raise vitamin D levels to a sufficient range within 15 days without altering blood calcium, phosphorus, or alkaline phosphatase levels.

54
0
90%

In premature infants with low vitamin D, taking 1,000 IU of vitamin D3 by mouth every day for 15 days leads to higher blood levels of vitamin D than receiving one 15,000 IU injection, even when starting from the same low level.

54
0
79%

Premature infants with vitamin D deficiency had an average blood vitamin D level of 13.20 ng/mL, which is classified as severe deficiency, showing that severe deficiency is common in this group.

54
0
74%